文献速递MDS 与骨髓增殖性肿瘤

Toll样受体信号负调控缺陷导致骨髓增殖性肿瘤中TNF-α过度产生

Defective negative regulation of Toll-like receptor signaling leads to excessive TNF-α in myeloproliferative neoplasm.
PubMed 文献 · Blood Adv · 2019-01-01

本研究发现骨髓增殖性肿瘤(MPN)患者单核细胞对Toll样受体(TLR)信号的负调控存在缺陷,IL-10不能抑制TLR激活后肿瘤坏死因子α(TNF-α)的产生,且该缺陷不直接由JAK2 V617F导致,在JAK2 V617F阳性患者的野生型单核细胞及未患病同卵双胞胎中同样存在。

要点

  • MPN患者单核细胞对IL-10负调控不敏感,TLR激活后TNF-α持续产生。
  • TNF-α持续产生并非JAK2 V617F直接后果,野生型单核细胞同样存在。
  • 未患病同卵双胞胎亦发现TNF-α持续产生,提示可能是MPN易感的内在特征。

核心结论

  • MPN患者单核细胞TLR信号负调控缺陷导致TLR激活后TNF-α不受控产生。
  • 该缺陷不直接由JAK2 V617F导致,JAK2 V617F阳性患者的野生型单核细胞同样存在。
  • 持续TLR信号既参与MPN慢性炎症状态,也可能是获得MPN的易感因素。

研究设计与样本

  • 研究纳入MPN患者及一例未患病同卵双胞胎,比较单核细胞对TLR激活和IL-10的反应。

主要发现

  • MPN患者单核细胞对IL-10不敏感,TLR激活后TNF-α持续产生。
  • JAK2 V617F阳性患者的JAK2 V617F和野生型单核细胞均表现为TNF-α持续产生。
  • 一例MPN患者的未患病同卵双胞胎也发现TNF-α持续产生。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Patients with myeloproliferative neoplasms (MPN) have high levels of inflammatory cytokines, some of which drive many of the debilitating constitutional symptoms associated with the disease and may also promote expansion of the neoplastic clone. We report here that monocytes from patients with MPN have defective negative regulation of Toll-like receptor (TLR) signaling that leads to unrestrained production of the inflammatory cytokine tumor necrosis factor α (TNF-α) after TLR activation. Specifically, monocytes of patients with MPN are insensitive to the anti-inflammatory cytokine interleukin 10 (IL-10) that negatively regulates TLR-induced TNF-α production. This inability to respond to IL-10 is a not a direct consequence of JAK2 V617F , as the phenotype of persistent TNF-α production is a feature of JAK2 V617F and wild-type monocytes alike from JAK2 V617F -positive patients. Moreover, persistent TNF-α production was also discovered in the unaffected identical twin of a patient with MPN, suggesting it could be an intrinsic feature of those predisposed to acquire MPN. This work implicates sustained TLR signaling as not only a contributor to the chronic inflammatory state of MPN patients but also a potential predisposition to acquire MPN.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Lai HY, Brooks SA, Craver BM, et al. Defective negative regulation of Toll-like receptor signaling leads to excessive TNF-α in myeloproliferative neoplasm. Blood Adv. 2019. PMID: 30647074. doi:10.1182/bloodadvances.2018026450

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。